Published in Virology on April 25, 2006
Identifying protein phosphorylation sites with kinase substrate specificity on human viruses. PLoS One (2012) 0.93
Molecular determinants of human T-lymphotropic virus type 1 transmission and spread. Viruses (2011) 0.92
Cellular kinases incorporated into HIV-1 particles: passive or active passengers? Retrovirology (2011) 0.85
Phosphorylation Requirement of Murine Leukemia Virus p12. J Virol (2016) 0.77
H11/HSPB8 Restricts HIV-2 Vpx to Restore the Anti-Viral Activity of SAMHD1. Front Microbiol (2016) 0.75
Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest (2006) 3.34
The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol (2002) 3.01
Clinical and electrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospective study. Lancet Neurol (2006) 2.50
The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J Biol Chem (2003) 2.02
Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res (2007) 1.95
Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding. J Cell Sci (2004) 1.67
HBZ interacts with JunD and stimulates its transcriptional activity. FEBS Lett (2004) 1.63
Replication cycle of chikungunya: a re-emerging arbovirus. Virology (2009) 1.61
The Chikungunya threat: an ecological and evolutionary perspective. Trends Microbiol (2008) 1.56
The European definitions of the key features of the discipline of general practice: the role of the GP and core competencies. Br J Gen Pract (2002) 1.56
Role of the intracellular domains of CXCR4 in SDF-1-mediated signaling. Blood (2002) 1.45
Negativicoccus succinicivorans gen. nov., sp. nov., isolated from human clinical samples, emended description of the family Veillonellaceae and description of Negativicutes classis nov., Selenomonadales ord. nov. and Acidaminococcaceae fam. nov. in the bacterial phylum Firmicutes. Int J Syst Evol Microbiol (2009) 1.38
Induction of a peptide with activity against a broad spectrum of pathogens in the Aedes aegypti salivary gland, following Infection with Dengue Virus. PLoS Pathog (2011) 1.30
HBZ, a new important player in the mystery of adult T-cell leukemia. Blood (2006) 1.27
Nuclear localization of HTLV-I bZIP factor (HBZ) is mediated by three distinct motifs. J Cell Sci (2005) 1.27
Chikungunya triggers an autophagic process which promotes viral replication. Virol J (2011) 1.26
Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein. J Biol Chem (2003) 1.23
Discontinuous epitope prediction based on mimotope analysis. Bioinformatics (2006) 1.22
Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells. EMBO J (2010) 1.18
Apoptosis of uninfected cells induced by HIV envelope glycoproteins. Retrovirology (2004) 1.16
Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments. PLoS One (2010) 1.16
The host cell MAP kinase ERK-2 regulates viral assembly and release by phosphorylating the p6gag protein of HIV-1. J Biol Chem (2004) 1.14
Veillonella montpellierensis sp. nov., a novel, anaerobic, Gram-negative coccus isolated from human clinical samples. Int J Syst Evol Microbiol (2004) 1.14
Jonquetella anthropi gen. nov., sp. nov., the first member of the candidate phylum 'Synergistetes' isolated from man. Int J Syst Evol Microbiol (2007) 1.13
Phylogenetic analysis of some Sporomusa sub-branch members isolated from human clinical specimens: description of Megasphaera micronuciformis sp. nov. Int J Syst Evol Microbiol (2003) 1.09
The human polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1. J Virol (2003) 1.04
VSV-G pseudotyping rescues HIV-1 CA mutations that impair core assembly or stability. Retrovirology (2008) 1.03
Parallel kinetic analysis and affinity determination of hundreds of monoclonal antibodies using the ProteOn XPR36. Anal Biochem (2008) 1.03
The highly structured encapsidation signal of MuLV RNA is involved in the nuclear export of its unspliced RNA. J Mol Biol (2005) 1.02
The development of self-efficacy beliefs during general practice vocational training: an exploratory study. Med Teach (2009) 1.02
Production and characterization of mouse monoclonal antibodies reactive to Chikungunya envelope E2 glycoprotein. Virology (2007) 1.01
Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses. Infect Genet Evol (2011) 1.01
Dialister micraerophilus sp. nov. and Dialister propionicifaciens sp. nov., isolated from human clinical samples. Int J Syst Evol Microbiol (2005) 0.99
What does it mean to be a family physician?: Exploratory study with family medicine residents from 3 countries. Can Fam Physician (2009) 0.98
Acidaminococcus intestini sp. nov., isolated from human clinical samples. Int J Syst Evol Microbiol (2007) 0.97
PEPOP: computational design of immunogenic peptides. BMC Bioinformatics (2008) 0.96
Polarized expression of the membrane ASP protein derived from HIV-1 antisense transcription in T cells. Retrovirology (2011) 0.94
Autophagy and CD4+ T lymphocyte destruction by HIV-1. Autophagy (2007) 0.90
Cellulose membrane supported peptide arrays for deciphering protein-protein interaction sites: the case of PIN, a protein with multiple natural partners. Mol Divers (2004) 0.90
Refined study of the interaction between HIV-1 p6 late domain and ALIX. Retrovirology (2008) 0.89
The central region of human T-cell leukemia virus type 1 Tax protein contains distinct domains involved in subunit dimerization. J Virol (2003) 0.89
A peptide mimetic of an anti-CD4 monoclonal antibody by rational design. Biochem Biophys Res Commun (2003) 0.89
Intracellular assembly and budding of the Murine Leukemia Virus in infected cells. Retrovirology (2006) 0.89
NF-kappaB activation upon interaction of HIV-1 envelope glycoproteins with cell surface CD4 involves IkappaB kinases. FEBS Lett (2002) 0.88
The inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain. Virol J (2008) 0.88
Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope. Proteomics (2007) 0.88
Electron microscopy observation of human bocavirus (HBoV) in nasopharyngeal samples from HBoV-infected children. J Clin Microbiol (2007) 0.87
Uracil DNA Glycosylase 2 negatively regulates HIV-1 LTR transcription. Nucleic Acids Res (2009) 0.87
Synthesis and biological evaluation of a new derivative of bevirimat that targets the Gag CA-SP1 cleavage site. Eur J Med Chem (2013) 0.86
General practice as seen through the eyes of general practice trainees: a qualitative study. Scand J Prim Health Care (2006) 0.86
Cellular kinases incorporated into HIV-1 particles: passive or active passengers? Retrovirology (2011) 0.85
Caffeic acid phenethyl ester (CAPE) prevents inflammatory stress in organotypic hippocampal slice cultures. Brain Res Mol Brain Res (2003) 0.85
pH-dependent entry of chikungunya virus into Aedes albopictus cells. Infect Genet Evol (2012) 0.83
The anti-Müllerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand. Biochem J (2004) 0.82
Isolation of infectious chikungunya virus and dengue virus using anionic polymer-coated magnetic beads. J Virol Methods (2013) 0.82
Monoclonal antibody 76F distinguishes IA-2 from IA-2beta and overlaps an autoantibody epitope. J Autoimmun (2006) 0.81
Comparative properties of two peptide-antibody interactions as deduced from epitope delineation. J Immunol Methods (2002) 0.81
Cough determinants in patients with neuromuscular disease. Respir Physiol Neurobiol (2005) 0.80
Vpr expression abolishes the capacity of HIV-1 infected cells to repair uracilated DNA. Nucleic Acids Res (2013) 0.80
Identification of a highly conserved surface on Tat variants. J Biol Chem (2013) 0.80
Assessing chronic pain in general practice: are guidelines relevant? A cluster randomized controlled trial. Eur J Gen Pract (2006) 0.79
HIV-1-associated PKA acts as a cofactor for genome reverse transcription. Retrovirology (2013) 0.79
MASK-rhinitis, a single tool for integrated care pathways in allergic rhinitis. World Hosp Health Serv (2015) 0.78
Functional analysis of backbone cyclic peptides bearing the arm domain of the HIV-1 Rev protein: characterization of the karyophilic properties and inhibition of Rev-induced gene expression. Biochemistry (2005) 0.78
Plasma cortisol levels in Guillain-Barré syndrome. Crit Care Med (2009) 0.78
Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif. J Biomed Sci (2007) 0.78
[Autophagy and CD4 T lymphocyte destruction by HIV-1]. Med Sci (Paris) (2006) 0.78
Electrostatic repulsion between HIV-1 capsid proteins modulates hexamer plasticity and in vitro assembly. Proteins (2010) 0.77
The role of coagulation marker fibrin D-dimer in early diagnosis of catatonia. Psychiatry Res (2009) 0.77
N-truncated Aβ peptides in complex fluids unraveled by new specific immunoassays. Neurobiol Aging (2012) 0.77
Mapping the paratope of anti-CD4 recombinant Fab 13B8.2 by combining parallel peptide synthesis and site-directed mutagenesis. J Biol Chem (2003) 0.77
Artificial nucleobase-amino acid conjugates: a new class of TAR RNA binding agents. Chemistry (2014) 0.76
Long-term mechanical ventilation equipment for neuromuscular patients: meeting the expectations of patients and prescribers. Respir Care (2013) 0.76
Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule. Clin Immunol (2006) 0.75
Montpellier Infectious Diseases (MID), 2nd annual meeting (2012). Infect Genet Evol (2013) 0.75
[Updating of the European definition of general practice]. Presse Med (2013) 0.75